Malaysian Organization of Pharmaceutical Industries will be organizing the 2nd Regulatory Seminar in 2021 on 23 & 24 November 2021. This is a collaboration with the National Pharmaceutical Regulatory Agency (NPRA) and USP.
Day 1: Good Submission Practice - Quest 3 & Screening Requirement Do and Don’t for Generics, Health Supplement, Traditional Medicines and Biologics.
Day 2: Nitrosamine - Overview, Risk Assessment, Test Method and Analytical Procedure.
Registration deadline: 16 November 2021
Brochure Link: MOPI - NPRA 2nd Regulatory Seminar 23 - 24 Nov 2021.pdf - Google Drive
Processing: MOPI - NPRA 2nd Regulatory Seminar 23 - 24 Nov 2021.pdf…